Imaging Today the Medicine of Tomorrow
|Molecular imaging is an indispensable tool in studying human diseases and drug discovery. Pre-clinical imaging allows longitudinal and translational research for identifying disease pathways, determining mechanism of actions, evaluating drug efficacy, and monitoring their effects on disease progression in living animals. IBB provides state-of-the-art imaging solutions to investigate human diseases using molecular physiology and advanced bioimaging tools and help enhance the efficiency and pace of drug discovery and development.|
Scope of Services
IBB provides an augmented fee-for-service capability offering a comprehensive array of standard and bespoke preclinical imaging solutions in oncology, neuroscience , cardiology, metabolic diseases and diagnostic imaging.
As an A*STAR Research Institute, with a multidisciplinary team of investigators and strong ties to the other research institutes, IBB can provide specialised cutting-edge solutions to augment and advance your preclinical research.
|IBB offers a comprehensive array of dedicated multi-modal preclinical imaging resources unmatched in the commercial space.|
Nuclear Imaging:1. Positron Emission Tomography (PET)
|2. Magnetic Resonance Imaging & Spectroscopy (MRI/MRS)|
Selected services are applicable for Tech Access* grant subsidy.
|*Terms and Conditions Apply|